GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Common Stock

Belluscura (FRA:9VQ) Common Stock : €1.67 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Common Stock?

Belluscura's quarterly common stock increased from Jun. 2022 (€1.55 Mil) to Dec. 2022 (€1.57 Mil) and increased from Dec. 2022 (€1.57 Mil) to Jun. 2023 (€1.67 Mil).

Belluscura's annual common stock increased from Dec. 2020 (€0.68 Mil) to Dec. 2021 (€1.37 Mil) and increased from Dec. 2021 (€1.37 Mil) to Dec. 2022 (€1.57 Mil).


Belluscura Common Stock Historical Data

The historical data trend for Belluscura's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Common Stock Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Common Stock
0.40 0.58 0.68 1.37 1.57

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Common Stock Get a 7-Day Free Trial Premium Member Only 1.28 1.37 1.55 1.57 1.67

Belluscura Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Belluscura (FRA:9VQ) Business Description

Traded in Other Exchanges
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines